Pharmacokinetic drug evaluation of dolutegravir plus rilpivirine for the treatment of HIV
Author:
Affiliation:
1. 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy
2. Clinical Pharmacology Unit, ASST Fatebenefratelli-Sacco, Milano, Italy
3. Whitwaterstrand University, Johannesburg, South Africa
Publisher
Informa UK Limited
Subject
Pharmacology,Toxicology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17425255.2017.1361929
Reference56 articles.
1. Long-acting antiviral agents for HIV treatment
2. Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients
3. Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
4. Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics;Journal of Antimicrobial Chemotherapy;2020-02-03
2. Drug–drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment;Expert Opinion on Drug Metabolism & Toxicology;2019-02-11
3. New Dual Combination of Dolutegravir-Rilpivirine for Switching to Maintenance Antiretroviral Therapy;Aids Reviews;2019-01-30
4. Validation and clinical application of a novel LC–MS method for quantification of dolutegravir in breast milk;Bioanalysis;2018-12
5. HIV Clinical Updates: New Single-Tablet Regimens;Annals of Pharmacotherapy;2018-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3